Marc William Elia
CEO & Chairperson of the BoardMr. Marc William Elia is CEO & Chairperson of the Board of Invivyd, Inc. from August 30, 2026. Mr. Elia was Independent Chairperson of the Board of Invivyd, Inc. from July 2022 to August 30, 2026. Mr. Elia was Director of Invivyd, Inc. until April 16, 2021. Mr. Elia is a Chief Investment Officer of M28 Capital Management L.P. Mr. Elia has been an Independent Director of SQZ Biotechnologies Company since May 2018. He serves as an Independent Director at Fractyl Health, Inc since June 2021. He served as a director at Adimab LLC. He served as President of N30 Pharmaceuticals, LLC. Mr. Elia Co-Founded Tiger Management Corp. Mr. Elia held previous roles in life sciences corporate strategy at Chiron Corporation Limited and L.E.K. Consulting. Prior to that, from January 2012 to September 2019, Mr. Elia served as a Partner at Bridger Capital, an investment fund. He was Director of Invivyd, Inc. (formerly known as Adagio Therapeutics, Inc.) July 2020 until April 16, 2021. Mr. Elia served as the Director of N30 Pharmaceuticals, LLC. Mr. Elia holds a B.A. in Economics from Carleton College.
Positions
- Company NameInvivyd, Inc.Stock CodeIVVDPositionCEO & Chairperson of the BoardColleagues
- WEWilliam E. DukeCFO and Principal Financial & Accounting Officer
- JAJill AndersenChief Legal Officer & Corporate Secretary
- TLTimothy LeeChief Commercial Officer
- RDRobert D. AllenChief Scientific Officer
- AGAjay Gopal RoyanLead Independent Director
- KFKevin F. McLaughlinIndependent Director
- TGTerrance G. McGuireIndependent Director
- TBTamsin BerryIndependent Director
